| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Biopharm Division | -$5.65M | -$6.4M | -$5.9M | -$6.2M | -$6.01M |
| Neuromodulation Division | -$700K | -$800K | -$700K | — | -$768K |
| Neurostimulation Division | -$626.5K | -$626.5K | -$626.5K | -$626.5K | — |
| Total | -$6.3M | -$7.14M | -$6.53M | -$6.63M | -$6.78M |
Neurostimulation Division is derived from annual filings.